Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
about
Comparison of Intravenous Anesthetic Agents for the Treatment of Refractory Status EpilepticusPharmacotherapy for Status EpilepticusEffects of clobazam for treatment of refractory status epilepticusRefractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and PentobarbitalStatus Epilepticus.Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomesPhosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.Topiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data AnalysisLacosamide in status epilepticus: Systematic review of current evidence.Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome.Refractory and super-refractory status epilepticus--an update.First-in-man allopregnanolone use in super-refractory status epilepticus.Functional outcome of prolonged refractory status epilepticus.Procalcitonin and mortality in status epilepticus: an observational cohort study.Predictive value of the Status Epilepticus Severity Score (STESS) and its components for long-term survival.New-onset refractory status epilepticus: Etiology, clinical features, and outcomeImmunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application.Evaluation of a clinical tool for early etiology identification in status epilepticus.(S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.Combination drug therapy for the treatment of status epilepticus.New understanding of nonconvulsive status epilepticus in adults: treatments and challenges.Distinguishing in-hospital and out-of-hospital status epilepticus: clinical implications from a 10-year cohort study.Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.Treating epileptic emergencies - pharmacological advances.Hidden in plain sight: Non-convulsive status epilepticus-Recognition and management.Acute Resective Surgery for the Treatment of Refractory Status Epilepticus.Anesthetic-Related Neurotoxicity and Neuroimaging in Children: A Call for Conversation.Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.Therapeutic coma for status epilepticus: Differing practices in a prospective multicenter study.Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.Association of seizure duration and outcome in refractory status epilepticus.Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus.Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study.Nonconvulsive Seizures and Periodic Discharges: No Longer Such Innocent Bystanders.Finding the Lesser of Two Evils: Treating Refractory Status Epilepticus.Socioeconomic Outcome and Quality of Life in Adults after Status Epilepticus: A Multicenter, Longitudinal, Matched Case-Control Analysis from Germany.Early predictors of refractory status epilepticus: an international two-center study.
P2860
Q26746873-79FFCBE4-7836-4596-B100-CA090CE29540Q26796689-44E19141-9994-4CF6-BB34-DAA4C7DF1B70Q28821401-7608AFBD-9F1C-40F6-B142-6FBA1C752F84Q30276170-47D80CFE-775D-4FDE-AB45-FF520A38CC0EQ30277237-0F1055E8-DF0D-4515-A116-AE27DB873197Q30278847-79A84433-4ACF-4A6B-84FF-D6FB30205B31Q30278891-03598EF7-1B72-4D2F-B42D-D5929D226CBCQ30396733-7846A4AE-DDD6-4EE4-9265-6CFF594FBF10Q30399934-B608C095-AAFB-4593-B828-9BF78DBBE3D8Q30703796-551E2038-9CBD-4467-A3AA-4CA14992996AQ30807706-E2203C40-3818-401F-8606-672DA8944022Q33753851-43C2D8B4-069A-457B-A562-F0C6B084F0C5Q35590568-38D9E2A5-4711-4CE7-B0E0-ABD09A72145AQ36139745-E5B54699-F00A-426C-BBDA-504E1FDF2E68Q36183506-864AEF35-0E3A-42AF-AE91-89683699A4A1Q36272258-4549CBA5-226F-4624-BEE9-60B67F906BE3Q36620651-E39A1C5D-A204-4A65-A4D6-5D9F068FA37CQ36909082-60ED7BA4-2F3B-4BFE-94F1-D32C7FE583D8Q37201609-8D461D65-BC7E-48DC-86ED-12AB011B82B6Q38513028-17D34E74-7092-4BB1-9621-C16FC49F055CQ38630760-448FAA7D-43A6-4588-ADF8-B3A869D6FE39Q38670344-162D466B-89C7-4D18-9888-A6368C6B31F4Q38691719-F7DFDA89-4A80-4720-AC70-29763F7264A1Q38815369-C8B6F539-42D9-4334-A550-26F91EB9914CQ38968069-41F00C32-6745-47D1-8CD8-FF34048C785BQ39112997-624ED3B9-ADF5-454B-902E-66B00A9ED8C4Q39208359-475A2014-329C-49CB-8ADF-767486F76ACCQ39250965-330012AF-89E6-4B27-81C5-3EBBCF42F8DCQ39278813-705AC3E7-C47C-4604-BE36-73C0531256DFQ39354540-D5FCF1AF-B121-45BF-B001-A7EB384B490DQ39797473-39BF9ECC-D1EF-471A-9D93-3807FFA57410Q40150721-9A3E867E-2D69-49C7-ACDB-C4869903599CQ40236390-063A1CDC-7631-4A04-AD03-408AA110C6E3Q40799423-ABB80333-28FC-4E13-A0FD-615F2AA87A80Q41318447-05E521D2-A912-4EA1-B44B-8AD98382F7F5Q41494364-D228EDDB-C4E5-4212-B99E-180461086B48Q41596667-05B87B90-E6C4-42EB-B87E-0404C9802D8AQ42178351-1F4901E4-0062-476D-B5CB-82185A4E6764Q42368392-EBF1BC84-6B1F-4E26-A484-A11B2268630FQ43650360-09FE75F9-8EFA-4DD9-8D53-D0AAAED7A34D
P2860
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@en
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@nl
type
label
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@en
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@nl
prefLabel
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@en
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study.
@nl
P2093
P2860
P1433
P1476
Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study
@en
P2093
Peter Fuhr
Peter W Kaplan
Stephan Marsch
Stephan Rüegg
P2860
P304
P356
10.1212/WNL.0000000000000009
P407
P577
2013-12-06T00:00:00Z